PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400986
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400986
Asia Pacific Patient Registry Software Market size was valued at USD 323.3 Million in 2022, expanding at a CAGR of 12.5% from 2023 to 2030.
Patient registries are becoming more and more crucial to the medical system. Patient registries can be used for many different things, such as tracking results, researching new patterns, and examining best practices. Despite the long history of patient registries, data collection and analysis are now simpler than ever thanks to the usage of electronic health records.
Patient Registry Software Market- Market Dynamics
Increasing adoption of electronic health records (EHR) along with supportive government initiatives is expected to propel market demand
The formation of government programs to create patient registries, the growing use of electronic health records (EHR), and the growing post-marketing monitoring application of patient registry data. Government sources have begun to pay attention to electronic health records because of its many uses, both clinical and non-clinical. Governments in rich and developing nations alike are launching a plethora of federal laws, initiatives, and projects to advance healthcare services. Because more people are using patient registry software to track patient information and vaccine supply information, the COVID-19 pandemic has had a positive effect on the industry. These factors are expected to contribute to Asia Pacific patient registry software market.
Patient Registry Software Market- Key Insights
As per the analysis shared by our research analyst, the Asia Pacific market is estimated to grow annually at a CAGR of around 12.5% over the forecast period (2023-2030)
Based on Type segmentation, disease registry type segment was predicted to show maximum market share in the year 2022, The increasing cases of cardiovascular, diabetic disorders is boosting the market growth.
Based on Software Type segmentation, integrated software segment was the leading market in 2022, due to increasing adoption of integrated software and IT system in hospitals.
Based on End--User segmentation, hospitals were the leading market in 2022, due to increasing use of registry system at major medical and clinical needs in hospitals.
On the basis of country, China was the leading revenue generator in 2022 mainly due to the recent COVID-19 crisis and growing IT Software utilization and developing healthcare infrastructure.
The Asia Pacific Patient Registry Software Market is segmented on the basis of Type, Software Type, End--User, and Region.
The market is divided into three categories based on Type: disease registry, health service registry and product registry. The disease registry segment dominates the market. The increasing adoption of registry software due to rising cases relating to cancer, diabetes, and other chronic diseases is contributing to segment growth.
The market is divided into two categories based on Software Type: standalone and integrated. The integrated software dominates the market and is likely to maintain its dominance during the forecast period. Advancement in software development and high demand for software registry in medical sector is expected to boost the segmental growth.
The market is divided into six categories based on End--User: hospitals, government organizations and third-party administrators (TPAs), pharmaceutical, biotechnology, medical device companies, and others. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. Pharmaceutical and biotech industries also need registry software for maintaining pharma drugs, all these factors are mainly boosting the market growth.
Patient Registry Software Market- Country Insights
Country wise, this market is widespread into India, China, South Korea, Japan, Australia, Thailand, Indonesia, Philippines, Malaysia, Taiwan, Vietnam, Hong Kong, New Zealand, Singapore, Myanmar, and the rest of the Asia-Pacific (APAC) region.
The Asia Pacific Patient Registry Software Market players are searching for new and economical approaches to provide patient-centered, technology-enabled healthcare services both within and outside of hospitals. Government sources have begun to pay attention to electronic health records because of its many uses, both clinical and non-clinical.
Throughout the study period, it is anticipated that the introduction of new patient registries around the globe and the implementation of crucial tactics like mergers and acquisitions will propel market expansion.
In April 2022, Cerner introduced a registry which will collect data from patients diagnosed with Type 2 and Type 3 Gaucher disease, an autosomal recessive disease.
The scope of this report covers the market by its major segments, which include as follows:
ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET KEY PLAYERS
Evado Clinical
Open Text Corporation
LUMEDX
IBM Corporation
Global Vision Technologies, Inc.
Dacima Software
Image Trend, Inc.
IQVIA
Liasion Technologies
McKesson Corporation
Syneos Health
Velos Inc
Others
ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY TYPE
Disease registry
Health service registry
Product registry
ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY SOFTWARE TYPE
Standalone
Integrated
ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY END--USER
Hospitals
Government organizations and Third-Party Administrators (TPA)
Pharmaceutical
Biotechnology
Medical device companies
Others
ASIA PACIFIC PATIENT REGISTRY SOFTWARE MARKET, BY REGION
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Malaysia
Taiwan
Vietnam
Hong Kong
New Zealand
Singapore
Myanmar
Rest of APAC